IRulya Therapeutics, Inc. (IRLA)
39.88
-0.06
(-0.15%)
USD |
NASDAQ |
Nov 20, 16:00
39.93
+0.05
(+0.13%)
After-Hours: 20:00
IRulya Therapeutics Cash and Short Term Investments (Annual) : 17.75M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 17.75M |
| December 31, 2024 | 40.78M |
| December 31, 2023 | 75.06M |
| December 31, 2022 | 90.18M |
| December 31, 2021 | 106.80M |
| Date | Value |
|---|---|
| December 31, 2020 | 133.82M |
| December 31, 2019 | 99.86M |
| December 31, 2018 | 71.72M |
| December 31, 2017 | 7.393M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Korsana Biosciences, Inc. | 3.24M |
| PepGen Inc. | 148.46M |
| Q32 Bio, Inc. | 48.30M |
| Bridgebio Oncology Therapeutics, Inc. | 425.46M |
| Oncolytics Biotech, Inc. | 5.202M |